Edition:
India

Pain Therapeutics announces positive regulatory guidance for Remoxy ER

Pain Therapeutics Inc : Pain Therapeutics announces positive regulatory guidance for Remoxy ER . Believe its now on track to make expeditious progress toward resubmission of Remoxy NDA . Pain Therapeutics Inc - expect to complete remoxy studies by year-end 2017, at a cost of approximately $3 mln-$4...

Tuesday, 21 Mar 2017

Pain Therapeutics announces positive regulatory guidance for Remoxy ER

Pain Therapeutics Inc : Pain Therapeutics announces positive regulatory guidance for Remoxy ER . Believe its now on track to make expeditious progress toward resubmission of Remoxy NDA . Pain Therapeutics Inc - expect to complete remoxy studies by year-end 2017, at a cost of approximately $3 mln-$4...

Tuesday, 21 Mar 2017

Avexis files for potential mixed shelf offering - SEC filing

Avexis Inc :Files for potential mixed shelf offering; size not disclosed - SEC filing.

Saturday, 18 Mar 2017

Aveo Pharmaceuticals files for non-timely 10-K - SEC filing

Aveo Pharmaceuticals Inc : Files for non-timely 10-K - SEC filing . Says identified a material weakness in its internal control over financial reporting. . Aveo Pharmaceuticals - based on preliminary figures, expects to report net loss of $0.39 per basic and diluted share, for year ended December...

Saturday, 18 Mar 2017

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.